An SCN9A channelopathy causes congenital inability to experience pain

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Nature

• Publication date

  2006-12-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature05413PMID 17167479PMCID PMC7212082
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sporadic onset of erythermalgia: A gain‐of‐function mutation in Nav1.7

  2006cited by this paper
• A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons.

  2006cited by this paper
• The role of sodium channels in chronic inflammatory and neuropathic pain.

  2006cited by this paper
• Early nonsense: mRNA decay solves a translational problem

  2006cited by this paper
• Correspondence and requests for materials should be addressed to:

  2006cited by this paper
• International Union of Pharmacology. XLVIII. Nomenclature and Structure-Function Relationships of Voltage-Gated Calcium Channels

  2005cited by this paper
• International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium Channels

  2005cited by this paper
• Neuropathic pain develops normally in mice lacking both Nav1.7 and Nav1.8

  2005cited by this paper
• Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons.

  2005cited by this paper
• Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia

  2004cited by this paper
• Expression of alternatively spliced sodium channel alpha-subunit genes. Unique splicing patterns are observed in dorsal root ganglia.

  2004cited by this paper
• Electrophysiological Properties of Mutant Nav1.7 Sodium Channels in a Painful Inherited Neuropathy

  2004cited by this paper
• Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain.

  2004cited by this paper
• Peripheral biomarkers of oxidative damage in Alzheimer's disease

  2003cited by this paper
• Distinct repriming and closed‐state inactivation kinetics of Nav1.6 and Nav1.7 sodium channels in mouse spinal sensory neurons

  2003cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Congenital insensitivity to pain: an update

  2003cited by this paper
• Roles of Tetrodotoxin (TTX)-Sensitive Na+ Current, TTX-Resistant Na+ Current, and Ca2+ Current in the Action Potentials of Nociceptive Sensory Neurons

  2002cited by this paper
• Can we conquer pain?

  2002cited by this paper
• Sodium channel beta subunits: anything but auxiliary.

  2001cited by this paper
• Sodium Channel β Subunits: Anything but Auxiliary

  2001cited by this paper
• Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons.

  2001cited by this paper
• From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels.

  2000cited by this paper
• Slow Closed-State Inactivation: A Novel Mechanism Underlying Ramp Currents in Cells Expressing the hNE/PN1 Sodium Channel

  1998cited by this paper
• Structure and function of voltage‐gated sodium channels

  1998cited by this paper
• Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons.

  1997cited by this paper
• A Novel Tetrodotoxin-sensitive, Voltage-gated Sodium Channel Expressed in Rat and Human Dorsal Root Ganglia*

  1997cited by this paper
• Molecular genetic approaches to nociceptor development and function.

  1996cited by this paper
• Spinal sensory neurons express multiple sodium channel α-subunit mRNAs

  1996cited by this paper
• Spinal sensory neurons express multiple sodium channel alpha-subunit mRNAs.

  1996cited by this paper
• Structure and functional expression of a new member of the tetrodotoxin‐sensitive voltage‐activated sodium channel family from human neuroendocrine cells.

  1995cited by this paper
• Dominantly transmitted congenital indifference to pain

  1990cited by this paper
• Not 'indifference to pain' but varieties of hereditary sensory and autonomic neuropathy.

  1983cited by this paper
• A case of congenital general pure analgesia

  1932cited by this paper
• Received

  1868cited by this paper

• Molecular determinant of low-voltage dependence of human Nav1.7 inactivation revealed by efficacy-based Nav1.7 selective inhibitor.

  2026cites this paper
• Shaping the Action Potential in Dorsal Root and Trigeminal Ganglia Neurons: Relevance to Pain Mechanisms

  2026cites this paper
• Disentangling Schwann Cell and Neuronal TRPA1 Function in Mouse Models of Familial Episodic Pain Syndrome

  2026cites this paper
• Suzetrigine for Acute Pain in the Emergency Department: A First-in-Class NaV1.8 Blocker.

  2026cites this paper
• Targeting Nav Channels for Pain Relief: Structural Insights and Therapeutic Opportunities

  2026influential citation
• FK506 causes pain by upregulating NaV1.7 channels in the spinal dorsal root ganglia of NaV1.7–ChR2 mice

  2026cites this paper
• The parabss1 Drosophila melanogaster as Model for Chronic Nociception: Insights Into Cannabidiol Analgesic Effects

  2026influential citation
• Mitochondrial energetic failure underlies FLVCR1-related sensory neuropathy.

  2026cites this paper
• Functional and molecular insights into muscle proprioceptors

  2025cites this paper
• Small-Fiber Neuropathy: An Etiology-Oriented Review

  2025cites this paper
• Small Fibre Pathology in Fibromyalgia: A review

  2025cites this paper
• Nociceptor sodium channels shape subthreshold phase, upstroke, and shoulder of action potentials

  2025cites this paper
• Artificial Uterus and Artificial Embryos: Unsolved Tasks

  2025cites this paper
• Mepyramine targets mutant Nav1.7 channels to relieve pain and erythema in primary erythromelalgia patients

  2025cites this paper
• NaVigating nociceptive neuron signaling pathways to arrive at pain relief.

  2025cites this paper
• Painless Nav1.7 mutations reveal function-critical residues in the outer vestibule and N-terminus

  2025influential citation
• US drug agency approves potent painkiller — the first non-opioid in decades

  2025cites this paper
• Preclinical Animal Models to Investigate the Role of Nav1.7 Ion Channels in Pain

  2025influential citation
• A pathological missense mutation in the deubiquitinase USP5 leads to insensitivity to pain.

  2025cites this paper
• Vers une nouvelle génération d’antidouleurs

  2025cites this paper
• Requirements for the neurodevelopmental disorder-associated gene ZNF292 in human cortical interneuron development and function

  2025cites this paper
• Modification of Closed-State Inactivation in Voltage-Gated Sodium Channel Nav1.7 by Two Novel Arachnid Toxins

  2025cites this paper
• Deciphering the Structural and Functional Effects of the R1150W Non-Synonymous Variant in SCN9A Linked to Altered Pain Perception

  2025cites this paper
• Refining the NaV1.7 pharmacophore of a class of venom‐derived peptide inhibitors via a combination of in silico screening and rational engineering

  2025influential citation
• Voltage-gated sodium channels in excitable cells as drug targets

  2025influential citation
• CRISPR: fundamental principles and implications for anaesthesia

  2025cites this paper
• Small fiber neuropathy: expanding diagnosis with unsettled etiology

  2025cites this paper
• Critical role of extracellular loops in differential modulations of TTX-sensitive and TTX-resistant Nav channels

  2025influential citation
• Design, synthesis, structure-activity relationship (SAR) and analgesic effect studies of novel arylsulfonamides as selective Nav1.7 inhibitors.

  2025cites this paper
• Indazole - an emerging privileged scaffold: synthesis and its biological significance.

  2025cites this paper
• Suzetrigine, a selective NaV1.8 inhibitor in acute and chronic pain: mechanistic insights, clinical outcomes, and future perspectives.

  2025cites this paper
• Differential encoding of mammalian proprioception by voltage-gated sodium channels

  2025influential citation
• Intrathecal administration of the Nav1.7 inhibitor PF-05089771 produces rapid and side-effect-free analgesia in mice.

  2025cites this paper
• Arrestin-Biased Neurotensin Receptor 1 Signaling: A Promising Target for Novel Non-Opioid Pain Killers

  2025cites this paper
• Recent advances in the pharmacology of voltage-gated ion channels.

  2025cites this paper
• Integrated bioinformatics screening and experimental validation: construction of a LUAD prediction model based on Treg-related genes

  2025cites this paper
• NRF2 Activation Resolves Neuropathic Pain Via Dual Antioxidant And NaV1.7-Suppressive Mechanisms.

  2025cites this paper
• Comprehensive Proteomic Profiling of Human Nav1.7-Interacting Proteins Reveals Conserved Regulatory Networks Involved in Nociceptive Signaling

  2025cites this paper
• Nav1.8, an analgesic target for nonpsychotomimetic phytocannabinoids

  2025cites this paper
• α‐Adrenoreceptor blocker phentolamine inhibits voltage‐gated sodium channels via the local anaesthetic binding site

  2025cites this paper
• Suzetrigine: A New Analgesic Approved by the FDA

  2025cites this paper
• Neuronal p38 MAPK Signaling Contributes to Cisplatin-Induced Peripheral Neuropathy

  2025cites this paper
• Post-operative analgesic regime in a patient with congenital indifference to pain

  2025cites this paper
• Sensory neuron sodium channels as pain targets; from cocaine to Journavx (VX-548, suzetrigine).

  2025cites this paper
• Clinical features and functional analysis of novel SCN9A variants causing congenital insensitivity to pain.

  2025cites this paper
• Gasochromic-triboelectric-photodynamic multimodal patch for wound sensing and healing with congenital insensitivity to pain

  2025cites this paper
• Identification of the peptide Vulnusin, a wound signal that mediates mechanical-injury-induced nociception in Drosophila.

  2025cites this paper
• Voltage-gated sodium channels (NaV) in GtoPdb v.2025.3

  2025cites this paper
• Nociceptors use multiple neurotransmitters to drive pain

  2025cites this paper
• Brief analysis of Nav1.7 inhibitors: Mechanism of action and new research trends.

  2025cites this paper
• Voltage-Gated Ion Channels in Neuropathic Pain Signaling

  2025cites this paper
• Advances in Therapeutic Applications of CRISPR Genome Editing for Spinal Pain Management

  2025cites this paper
• Secondary chelation through shared water provides ion selectivity in bacterial sodium channels.

  2025cites this paper
• SARS-CoV-2 N protein interacts with Nav1.7 to promote pathological pain.

  2025cites this paper
• Sensory neuron–expressed FGF13 controls nociceptive signaling in diabetic neuropathy models

  2025cites this paper
• Ocular Manifestations in Congenital Insensitivity to Pain with Anhidrosis: A Window into a Rare Syndrome

  2025cites this paper
• The pharmacotherapeutic potential of neuropeptide Y for chronic pain

  2025cites this paper
• Histone lactylation regulates DOCK4 to control heat nociception and supports Dynein-mediated Nav1.7 trafficking

  2025cites this paper
• Arrestin-biased allosteric modulator of neurotensin receptor 1 alleviates acute and chronic pain.

  2025cites this paper
• Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective NaV1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain

  2025cites this paper
• Molecular Mechanisms of Chronic Pain and Therapeutic Interventions

  2025cites this paper
• Towards development of Nav1.7 channel modulators for pain treatment: A comparison of mexiletine effect in two cell models by automated patch clamp.

  2025cites this paper
• Epigenome editing based treatment: Progresses and challenges.

  2025cites this paper
• Phentolamine selectively blocks C-fiber conduction in different species, including humans

  2025cites this paper
• Ion-channel mRNA expression alterations in a cervical dorsal horn compression induced novel rabbit model of trigeminal neuropathic pain

  2025cites this paper
• Six at Sixty. ‘No gain, no pain’: medical genetics taking Nav1.7 from target to pharmacy

  2025cites this paper
• Modern assays for assessing pain and related nociceptive and defensive actions in rodent models.

  2025cites this paper
• Association of compression pressure and SCN8A and SCN9A gene polymorphisms with the recurrence of balloon compression-treated trigeminal neuralgia

  2025cites this paper
• Neuropharmacology and physiology of human dorsal root ganglion neurons responsible for nociception: state-of-the-art and future directions.

  2025cites this paper
• Gene Therapy and Epigenetic Modulation in Chronic Pain: A Future Without Opioids?

  2025cites this paper
• White matter reorganization of motor and affective-motivational networks in pain-indifferent carriers of the R221W mutation

  2025cites this paper
• Efficient genetic perturbation of murine sensory neurons in vivo using CRISPR/Cas9

  2025cites this paper
• Canaux ioniques et douleur : la suzétrigine, une nouvelle molécule antalgique inhibitrice du canal sodique voltage-dépendant Nav-1.8

  2025cites this paper
• Sodium channel modulation as a therapeutic strategy for chemotherapy-induced peripheral neurotoxicity

  2025cites this paper
• Ion channels of cold transduction and transmission

  2024cites this paper
• Vitamin B5 is a context-dependent dietary regulator of nociception

  2024cites this paper
• Optical genome mapping identifies a homozygous deletion in the non-coding region of the SCN9A gene in individuals from the same family with congenital insensitivity to pain

  2024cites this paper
• Small molecule targeting NaV1.7 via inhibition of CRMP2-Ubc9 interaction reduces pain-related outcomes in a rodent osteoarthritic model.

  2024cites this paper
• Conotoxins Targeting Voltage-Gated Sodium Ion Channels

  2024cites this paper
• Out of the dark: the emerging roles of lncRNAs in pain.

  2024cites this paper
• Pathology of pain and its implications for therapeutic interventions

  2024cites this paper
• The road to evolution of ProTx2: how to be a subtype-specific inhibition of human Nav1.7

  2024cites this paper
• Similar excitability through different sodium channels and implications for the analgesic efficacy of selective drugs.

  2024cites this paper
• ST‐2560, a selective inhibitor of the NaV1.7 sodium channel, affects nocifensive and cardiovascular reflexes in non‐human primates

  2024influential citation
• Die EAN-NeuPSIG-Leitlinie zur Diagnostik bei neuropathischen Schmerzen – eine Kurzfassung

  2024cites this paper
• Analgesic effect of Botulinum toxin in neuropathic pain is sodium channel independent.

  2024cites this paper
• Nav1.7 Modulator Bearing a 3-Hydroxyindole Backbone Holds the Potential to Reverse Neuropathic Pain.

  2024cites this paper
• Role of NaV1.7 in postganglionic sympathetic nerve function in human and guinea‐pig arteries

  2024influential citation
• Shining a Light on Venom-Peptide Receptors: Venom Peptides as Targeted Agents for In Vivo Molecular Imaging

  2024cites this paper
• Ion channels in osteoarthritis: emerging roles and potential targets

  2024cites this paper
• Novel therapies for cancer-induced bone pain

  2024influential citation
• Role of macrophages in trigeminal ganglia in ectopic orofacial pain associated with pulpitis.

  2024cites this paper
• Identification and In-Silico study of non-synonymous functional SNPs in the human SCN9A gene

  2024cites this paper
• Transient peripheral blood transcriptomic response to ketamine treatment in children with ADNP syndrome

  2024cites this paper
• Scorpion α-toxin LqhαIT specifically interacts with a glycan at the pore domain of voltage-gated sodium channels

  2024cites this paper
• Mechanisms of pain in aging and age-related conditions: focus on caregivers.

  2024cites this paper
• A challenging diagnosis of chronic osteomyelitis in a child with congenital insensitivity to pain: a case report

  2024cites this paper
• Chronic intermittent hypoxia elicits distinct transcriptomic responses among neurons and oligodendrocytes within the brainstem of mice.

  2024cites this paper
• Autonomic Dysfunction Linked to Inhibition of the Nav1.7 Sodium Channel

  2024cites this paper
• Compartment-specific regulation of NaV1.7 in sensory neurons after acute exposure to TNF-α

  2024cites this paper